1. Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse. Issue 8 (3rd July 2019) Authors: Goldschmidt, Neta; Horowitz, Netanel A.; Heffes, Vered; Darawshy, Fares; Mashiach, Tatiana; Shaulov, Adir; Gatt, Moshe E.; Dann, Eldad J. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 8(2019) Page Start: 1890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia. (July 2019) Authors: Tadmor, Tamar; Levy, Ilana; Herishanu, Yair; Goldschmidt, Neta; Bairey, Osnat; Yuklea, Mona; Shvidel, Lev; Fineman, Riva; Aviv, Ariel; Ruchlemer, Rosa; Braester, Andrei; Dally, Najib; Rouvio, Ory; Shaulov, Adir; Greenbaum, Uri; Inbar, Michal; Polliack, Aaron Journal: Leukemia research Issue: Volume 82(2019) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma. (April 2018) Authors: El-Galaly, Tarec Christoffer; Cheah, Chan Yoon; Bendtsen, Mette Dahl; Nowakowski, Grzegorz S.; Kansara, Roopesh; Savage, Kerry J.; Connors, Joseph M.; Sehn, Laurie H.; Goldschmidt, Neta; Shaulov, Adir; Farooq, Umar; Link, Brian K.; Ferreri, Andrés J.M.; Calimeri, Teresa; Cecchetti, Caterina; Dann... Journal: European journal of cancer Issue: Volume 93(2018) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia. Issue 11 (November 2014) Authors: Vine, Jacob; Cohen, Sara Bar; Ruchlemer, Rosa; Goldschmidt, Neta; Levin, Moshe; Libster, Diana; Gural, Alexander; Gatt, Moshe E.; Lavie, David; Ben-Yehuda, Dina; Rund, Deborah Journal: Leukemia & lymphoma Issue: Volume 55:Issue 11(2014:Nov.) Page Start: 2525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group. Issue 6 (14th March 2020) Authors: Herishanu, Yair; Shaulov, Adir; Fineman, Riva; Bašić‐Kinda, Sandra; Aviv, Ariel; Wasik‐Szczepanek, Ewa; Jaksic, Ozren; Zdrenghea, Mihnea; Greenbaum, Uri; Mandac, Inga; Simkovic, Martin; Morawska, Marta; Benjamini, Ohad; Spacek, Martin; Nemets, Anatoly; Bairey, Osnat; Trentin, Livio; Ruchlemer, Ro... Journal: American journal of hematology Issue: Volume 95:Issue 6(2020:Jun.) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study. (24th November 2021) Authors: Morgenstern, Yael; Aumann, Shlomzion; Goldschmidt, Neta; Gatt, Moshe E.; Nachmias, Boaz; Horowitz, Netanel A. Journal: Cancer medicine Issue: Volume 10:Number 24(2021) Page Start: 8866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. Issue 2 (21st November 2016) Authors: Shaulov, Adir; Ganzel, Chezi; Benyamini, Noam; Barshay, Yossef; Goldschmidt, Neta; Lavie, David; Libster, Diana; Gural, Alex; Avni, Batia; Gatt, Moshe E. Journal: American journal of hematology Issue: Volume 92:Issue 2(2017:Feb.) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study. Issue 4 (April 2021) Authors: Kuruvilla, John; Ramchandren, Radhakrishnan; Santoro, Armando; Paszkiewicz-Kozik, Ewa; Gasiorowski, Robin; Johnson, Nathalie A; Fogliatto, Laura Maria; Goncalves, Iara; de Oliveira, Jose S R; Buccheri, Valeria; Perini, Guilherme F; Goldschmidt, Neta; Kriachok, Iryna; Dickinson, Michael; Komarnick... Journal: Lancet oncology Issue: Volume 22:Issue 4(2021) Page Start: 512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience. Issue 1 (2nd January 2021) Authors: Segman, Yafit; Ribakovsky, Elena; Avigdor, Abraham; Goldhecht, Yair; Vainstein, Vladimir; Goldschmidt, Neta; Harlev, Shimrit; Horwitz, Netanel; Gutwein, Odit; Gurion, Ronit; Itchaki, Gilad; Abadi, Uri; Nemets, Anatoly; Sofer, Orit; Zektser, Miri; Tadmor, Tamar; Dally, Nagib; Filanovsky, Kalman; L... Journal: Leukemia & lymphoma Issue: Volume 62:Issue 1(2021) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The prognostic value of bone marrow involvement at the molecular level in aggressive lymphoma. Issue 1 (2nd January 2017) Authors: Goldschmidt, Neta; Darawshy, Fares; Kleinstern, Geffen; Slyusarevsky, Elena; Pogrebijski, Galina; Krichevsky, Svetlana; Ben-Yehuda, Dina; Gatt, Moshe E. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 1(2017) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗